SCN5A and Brugada syndrome: Mutations in SCN5A that pathologically decrease peak INa, i.e. “loss-of-function” effect, cause phenotypes including Brugada Syndrome (BrS), progressive cardiac conduction disease, and congenital sick sinus syndrome [6,7].